KPI data tables
Valneva operating metrics behind the KPI charts, newest period first (up to 24 periods per chart). Periods use each company's own fiscal labels where the source does; each table names its source.
| Period | Cash and cash equivalents |
|---|---|
| Q2 2026 | 121.5 |
| Q1 2026 | 105.3 |
| Q4 2025 | 109.7 |
| Q3 2025 | 143.5 |
| Q2 2025 | 161.3 |
| Q1 2025 | 153 |
| Q4 2024 | 168.3 |
Source: Valneva FY 2025 results PR (18 Mar 2026, https://valneva.com/wp-content/uploads/2026/03/2026_03_18_FY_2025_Results_PR_EN_Final.pdf): cash €109.7 million at 31 Dec 2025 and €168.3 million at 31 Dec 2024. Q1 2026 results PR (13 May 2026, https://valneva.com/wp-content/uploads/2026/05/2026_05_13_Q1_Results_PR_EN_Final.pdf): €105.3 million at 31 Mar 2026 and €153.0 million at 31 Mar 2025. H1 2025 results PR (https://valneva.com/wp-content/uploads/2025/08/2025_12_08_VLA_H1_Results_PR_EN_Final.pdf): €161.3 million at 30 Jun 2025. 9M 2025 results PR (20 Nov 2025, https://valneva.com/wp-content/uploads/2025/11/2025_11_20_VLA_Nine-Month_Results_EN_Final.pdf): €143.5 million at 30 Sep 2025. H1 2026 results PR (13 Aug 2026, https://valneva.com/wp-content/uploads/2026/08/2026_08_13_VLA_H1_2026_PR_EN_Final.pdf): €121.5 million at 30 Jun 2026; net offering proceeds €34.3 million; operating cash used €13.7 million.
| Period | IXIARO / JESPECT | DUKORAL | IXCHIQ | Third-party products |
|---|---|---|---|---|
| 2025 | 98.4 | 31.9 | 8.4 | 19.2 |
| 2024 | 94.1 | 32.3 | 3.7 | 33.2 |
| 2023 | 73.5 | 29.8 | 35.7 | |
| 2022 | 41.3 | 17.3 | 26.5 |
Source: Valneva FY 2024 Form 20-F Note 5.5.3 disaggregated revenue (€ thousand): 2022 IXIARO 41,349, DUKORAL 17,334, third-party 26,545; 2023 IXIARO 73,483, DUKORAL 29,775, third-party 35,675; 2024 IXIARO 94,069, DUKORAL 32,303, IXCHIQ 3,696, third-party 33,185 (https://www.sec.gov/Archives/edgar/data/1836564/000162828025014522/R13.htm). FY 2024 analyst presentation (https://valneva.com/wp-content/uploads/2025/03/2025_03_20_VLA_FY_2024_Results_Analyst-Presentation.pdf): 2023 IXIARO 73.5 / DUKORAL 29.8 / third-party 35.7; 2024 94.1 / 32.3 / 3.7 / 33.2. Valneva FY 2025 results PR (18 Mar 2026, https://valneva.com/wp-content/uploads/2026/03/2026_03_18_FY_2025_Results_PR_EN_Final.pdf) and FY 2025 analyst presentation (https://valneva.com/wp-content/uploads/2025/12/2026_03_18_FY-2025-Analyst-Presentation_final.pdf): 2025 IXIARO 98.4, DUKORAL 31.9, IXCHIQ 8.4, third-party 19.2.
| Period | IXIARO / JESPECT | DUKORAL | IXCHIQ | Third-party products |
|---|---|---|---|---|
| Q2 2026 (residual) | 23.8 | 6.1 | 2.8 | 0.9 |
| Q1 2026 | 20.2 | 8.6 | 1.6 | 0.1 |
| Q4 2025 (residual) | 24.1 | 10.4 | 0.8 | 3.1 |
| Q3 2025 (residual) | 19.6 | 4.1 | 0.1 | 4.7 |
| Q2 2025 (residual) | 27.2 | 5.1 | 4.5 | 5.6 |
| Q1 2025 | 27.5 | 12.3 | 3 | 5.8 |
Source: Valneva Q1 2026 results PR (13 May 2026, https://valneva.com/wp-content/uploads/2026/05/2026_05_13_Q1_Results_PR_EN_Final.pdf): Q1 2026 IXIARO 20.2, DUKORAL 8.6, IXCHIQ 1.6, third-party 0.1 (product sales 30.5); Q1 2025 IXIARO 27.5, DUKORAL 12.3, IXCHIQ 3.0, third-party 5.8 (product sales 48.6). H1 2026 results PR (13 Aug 2026, https://valneva.com/wp-content/uploads/2026/08/2026_08_13_VLA_H1_2026_PR_EN_Final.pdf) product-level table: H1 2026 IXIARO 44.0, DUKORAL 14.7, IXCHIQ 4.4, third-party 1.0 (product sales 64.0); H1 2025 IXIARO 54.7, DUKORAL 17.4, IXCHIQ 7.5, third-party 11.4 (product sales 91.0). 9M 2025 results PR (20 Nov 2025, https://valneva.com/wp-content/uploads/2025/11/2025_11_20_VLA_Nine-Month_Results_EN_Final.pdf): IXIARO 74.3, DUKORAL 21.5, IXCHIQ 7.6, third-party 16.1 (product sales 119.4). FY 2025 results PR (18 Mar 2026): IXIARO 98.4, DUKORAL 31.9, IXCHIQ 8.4, third-party 19.2 (product sales 157.9).